Name: Aldehyde Dehydrogenases: From Alcohol Metabolism to Human Health and Precision Medicine (en Inglés)
Price: 296189.00 COP
Availability: InStock
Author: Ren, Jun ; Zhang, Yingmei ; Ge, Junbo
ISBN: 9789811362620

portada Aldehyde Dehydrogenases: From Alcohol Metabolism to Human Health and Precision Medicine (en Inglés)

Aldehyde Dehydrogenases: From Alcohol Metabolism to Human Health and Precision Medicine (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Ren, Jun ; Zhang, Yingmei ; Ge, Junbo

Idioma

Inglés

N° páginas

253

Encuadernación

Tapa Blanda

ISBN13

9789811362620

Categorías

Fisiología
Bioquímica
Biología molecular

Aldehyde Dehydrogenases: From Alcohol Metabolism to Human Health and Precision Medicine (en Inglés)

Ren, Jun ; Zhang, Yingmei ; Ge, Junbo (Autor) · Springer · Tapa Blanda

Libro Nuevo Importado

Envío: 18 a 24 días háb.

$ 592.378$ 296.189

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 296.189

¡Envío Gratis! Llega entre el 01 Sep y el 10 Sep a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Aldehyde Dehydrogenases: From Alcohol Metabolism to Human Health and Precision Medicine (en Inglés)"

This volume covers the science of ALDH enzymes in relation to chronic disease processes and the future therapeutic potentials of targeting ALDH in these processes. It thoroughly reviews the roles of ALDH family in alcohol metabolism, as well as recent findings of their emerging roles in a variety of human pathologies such as cardiovascular diseases, diabetes, obesity, stroke, cancer, liver diseases and kidney diseases. Delicate contribution of ALDH enzymes in the therapeutics against chronic diseases is also discussed. It demonstrates the unique value of targeting genetic polymorphism in ALDH enzymes in personalized medicine. The book will appeal to scientists, physicians, graduate and professional students in the fields of ALDH enzymes, alcohol metabolism, cardiometabolic and other chronic diseases. Pharmaceutical and other companies developing new tools for cardiometabolic and chronic diseases treatment will also find this a valuable resource.